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ABSTRACTSday stroke/death on univariant analysis was preoperative stroke
(p¼0.02).
Conclusion: Rationale for CDUSS in asymptomatic patients pre CS is var-
iable and results in high numbers receiving CEA. National Guidelines for
CDUSS and CEA referral pre- CS are required.
1066: VASCULAR ALLOGRAFTS e THE UK PERSPECTIVE 2008-2012
Samuel Coulson, Fern Coxon, Dominic Dodd. Vascular Services, Shefﬁeld, UK.
Introduction: Cadaveric allografts provide one alternative for conduit
formation in peripheral vascular disease when autografts are unavailable
and prosthetic grafts pose too great a risk. We aimed to review the use of
vascular allografts in the UK to identify reasons for poor uptake.
Method: All incidences of vascular allografts in the UK were recorded.
Reporting forms at time of operation, then at regular intervals, were sent
to the operating surgeon. The forms recorded demographics, compre-
hensive management information, patient progress and professional
opinion.
Results: Allografts were used on eighteen occasions, including ﬁve
femoralepopliteal, three ilioefemoral and two aortoeiliac bypasses. Five
are currently in situ and ﬁve have been removed. Complications included
arterial infection, graft infection and severe limb ulceration. Users found
allografts easy to handle and many would utilise again.
Conclusion: Vascular allografts have not gained the widespread accep-
tance they have been afforded in Europe. The current dismal uptake will
delay the development of a solid evidence base and threaten the future of
the vascular allograft tissue bank. Users reported a good experience, with
the ultimate proof being repeated use by four surgeons. Will it take just
one exposure to highlight the practicalities of these grafts and encourage
further use?
1080: PERIOPERATIVE COMPLIANCE WITH VSGBI QUALITY IMPROVE-
MENT FRAMEWORK FOR MAJOR LIMB AMPUTATIONS IN A SINGLE
VASCULAR CENTRE
Matthew Kennedy, Nikhil Sharma, Sobath Premaratne, Anthony Jaipersad,
Arun Balakrishna, Catherine Merriman. Royal Shrewsbury and Telford
Hospitals NHS Trust, Shrewsbury, UK.
Aim: To determine whether our department complies with the quality
improvement framework for major amputations formulated by Vascular
Society of Great Britain and Ireland (VSGBI).
Methods: Retrospective audit of major limb amputations performed dur-
ing 12 month period until October 2012. Case notes, theatre records and
departmental vascular database were analysed and data collected using a
proforma formulated upon the VSBGI guideline.
Results: 41 patients had major amputations, 30 were male, average age
was 70.2 years (range 36-94). 22(54%) below-knee and 17(41.5%) above-
knee amputations were performed. All patients were assessed by a
vascular surgeon prior to surgery. 97%(39) procedures undertaken during
normal working hours. Following the decision to amputate, 73%(30) pa-
tients underwent the procedure within 48 hours. All operating surgeons
were either senior vascular registrars or performed under consultant su-
pervision. In 71%(29) anaesthesia was administered by a senior anaes-
thetist. Thromboprophylaxis administered for all patients and prophylactic
antibiotic therapy administered in 92%(38) of patients preoperatively.
Postoperatively all patients underwent physiotherapist led rehabilitation.
In-hospital mortality and 30-day mortality rates were 7.3%(3) and 9.7%(4)
respectively.
Conclusion: Perioperative management of lower limb amputations ac-
cording to the quality improvement framework published by VSGBI, can
be undertaken in a single vascular centre with acceptable outcome
results.
1149: CATHETER-DIRECTED THROMBOLYSIS IN ILIO-FEMORAL DEEP
VEIN THROMBOSIS
Hirah Rizki, Abhilash Paily, Gary Picken, Isam Osman, Abdusalam Abu-
Own. The Ipswich Hospital, Ipswich, UK.
Aim: The importance of thrombus removal through Catheter Directed
Thrombolysis (CDT) for acute ilio-femoral DVT is well recognized. The aim
of this study was to review outcomes following CDT in our hospital.
Methods: A retrospective review of case notes and imaging was under-
taken for all cases of CDT from January 2001 to December 2012. tPAwas used and administered through the popliteal vein. Patients were
thrombolysed for 24-72 hours. No patient had an IVC ﬁlter inserted prior
to CDT.
Results: 20 patients (mean age 36) underwent CDT for ilio-femoral DVTs.
Complete radiological clearance was achieved in 40% of patients. May-
Thurners Syndrome was identiﬁed as the leading cause in 30% of patients.
There was no in-hospital PE, cerebral bleeding or deaths. Minor bleeding,
from the catheter or cannula site, was noted in 64% of cases. One patient
developed recurrent DVT within 3month and three beyond 3months. One
patient developed a PE 7 months post CDT.
Conclusions: In our experience, CDT is a safe and successful treatment
option for ilio-femoral DVTs. Our local hospital guidelines for CDT have
facilitated the process of safe selection and delivery of this treatment. Our
results are in keeping with the ﬁndings of published data.
1167: THE POTENTIAL IMPACT ON CLINICAL OUTCOMES AND SERVICE
PROVISION OF VARIABILITY IN ULTRASOUND MEASUREMENT OF
PEAK SYSTOLIC VELOCITY IN A MULTI-CENTRE VASCULAR NETWORK
G. Martin, J.D. Hodgkinson, U. Jaffer, M. Aslam, N.J. Standﬁeld. Imperial
Vascular Unit, Imperial College Healthcare NHS Trust, St Mary’s Hospital
Campus, Paddington, London, UK.
Aims: Multi-centre snap shot assessment of peak systolic velocity (PSV)
measurement utilising a high ﬁdelity pulsatile ﬂow stimulator. Our aim is
to assess sources of variability in a multi-centre vascular network.
Methods: We assessed 12 operators, across 4 different sites, utilising a
reproducible waveform generated by a high ﬁdelity pulsatile ﬂow simu-
lator. Measurements of PSV with both pulsatile and continuous ﬂow
waveforms were assessed for potential sources of variability.
Results: Wide variability in measured PSV: Pulsatile waveform: mean
52.1cm/s (range 40.0 - 62.9cm/s) and continuous waveform: mean 51.2cm/
s (range 41.7 - 63.3cm/s). Cross-site variability was found to be greater than
intra-operator variability.
Conclusions: Sources of measurement variability include angle of inso-
nation, sample volume, internal spectral broadening, machine type and
calibration. Accurate and reproducible non-invasive grading of stenoses,
monitoring of their progression, and assessment of response to treatment
is crucial in managing peripheral vascular disease. The formation of
regional vascular networks following the VSGBI report, ‘Provision of Ser-
vices for Patients with Vascular Disease', means diagnostic duplex ultra-
sound maybe occurring on multiple sites by multiple operators.
Signiﬁcant variability in duplex ultrasound assessment across different
sites could lead to delayed, or mis-diagnosis of signiﬁcant lesions;
potentially leading to inappropriate invasive diagnostic procedures or
surgical interventions.
1169: ENDOVASCULAR ANEURYSM REPAIR IN NONAGENARIANS: A SYS-
TEMATIC REVIEW AND COMBINED ANALYSIS
James Wigley 1, Saran Shantikumar 2, Waseem Hameed 3, Ashok Handa 4.
1University Hospital Southampton, Southampton, UK; 2Bristol Heart Institute,
Bristol, UK; 3Kings College Hospital, London, UK; 4Nufﬁeld Department of
Surgery, Oxford, UK.
Aim: Endovascular aortic aneurysm repair (EVAR) promises a reduced
morbidity and mortality compared to open surgery, creating the oppor-
tunity for aneurysm repair in those previously considered unﬁt for inter-
vention. We determine the published incidence of complications and
survival after elective EVAR in nonagenarians.
Method: A systematic literature search was performed using the PubMed,
EMBASE and Cochrane databases up to December 2012. Two observers
independently screened search results and extracted data.
Results: Five retrospective reports were identiﬁed including 111 patients
(81% male) with a mean age of 91.6 years. The mean aneurysm size was
68.6mm. Comorbidities include hypertension (81%), ischaemic heart dis-
ease (50%), peripheral vascular disease (30%) and COPD (20%). There was
zero on-table mortality, 24 (22%) patients suffered perioperative medical
or surgical complications and 27 (24%) had endoleaks. Mean duration of
hospital stay was 4 days. Thirty-daymortality was 5%, and survival at 1-, 3-
and 5-years was 82%, 56% and 17% respectively.
Conclusions: The complication rates and longer-term survival after elec-
tive EVAR in carefully selected nonagenarians appears acceptable, but is
higher than reported in younger patients. The use of EVAR in this age
